Abstract
Covered stents or stent grafts are exciting new products with multiple applications for patients with vascular disease, including hemodialysis access-related complications. Although most of the current uses of stent grafts in these settings are "off-label" (ie, not approved by the US Food and Drug Administration) several studies are currently underway to provide the necessary data to support their application. It is clear that stent grafts provide a rapid, effective means for endovascular repair of ruptured access vessels. The commercially available devices and their current applications for treating access-related complications, including aneurysms/pseudoaneurysms, venous outflow stenoses, cephalic arch lesions, ruptures, and diffuse access stenoses, will be reviewed in this article. Available data are reported along with our current clinical practice and algorithms.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
